Novel targeted therapies for mantle cell lymphoma

Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy characterized by short median survival despite intensive therapies. The clinical behavior of MCL most likely relates to the complex pathophysiology of the disease which includes its genetic hallmark, the chromosomal translocation t(11;14)...

Descripción completa

Detalles Bibliográficos
Autores principales: Alinari, Lapo, Christian, Beth, Baiocchi, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326650/
https://www.ncbi.nlm.nih.gov/pubmed/22361516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326650/
https://www.ncbi.nlm.nih.gov/pubmed/22361516

Ejemplares similares